We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Varian Debuts BioStatic™ NMR Probe for Protein Applications
Product News

Varian Debuts BioStatic™ NMR Probe for Protein Applications

Varian Debuts BioStatic™ NMR Probe for Protein Applications
Product News

Varian Debuts BioStatic™ NMR Probe for Protein Applications


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Varian Debuts BioStatic™ NMR Probe for Protein Applications"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Varian, Inc. has extended its offerings for bio-solids applications research by introducing the BioStatic™ nuclear magnetic resonance probe designed to determine the molecular structures of proteins and other biomolecules in a solid state.

Bio-solids NMR experiments allow access to 70% of all cellular proteins, such as membrane proteins, that are considered solids because they are not free floating in intracellular fluid.

These analyses can provide researchers with unparalleled insight into proteins and biomarker molecules associated with a wide variety of diseases.

Varian's BioStatic probe incorporates patent pending ultra-low E-field coil technology to reduce unwanted heating by up to 94% compared to a standard solenoid coil design probe, and enables experiments to be run up to 5x faster than competitive offerings.

Low transfer of heat to the sample is important to researchers because heating can alter or destroy valuable biological solids samples.

"Membrane proteins are of considerable interest to our customers because they represent approximately 65 percent of current drug targets," said Martin O'Donoghue, senior vice president of Scientific Instruments, Varian, Inc.

"The BioStatic probe is another product in our information rich detection (IRD) portfolio that demonstrates the continuing innovation of our NMR research and development team."

Advertisement